Strid Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Strid Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$201K	Hold	1,000	–	–	0.02%	82
2025 Q4	$207K	Buy	+1,000	New	+$200K	0.03%	76
2018 Q3	–	Sell	-2,100	Closed	-$294K	–	25
2018 Q2	$294K	Hold	2,100	–	–	0.11%	20
2018 Q1	$288K	Hold	2,100	–	–	0.11%	18
2017 Q4	$262K	Hold	2,100	–	–	0.1%	24
2017 Q3	$260K	Hold	2,100	–	–	0.1%	22
2017 Q2	$239K	Buy	+2,100	New	+$226K	0.11%	21
2016 Q1	–	Sell	-156,463	Closed	-$17.7M	–	42
2015 Q4	$17.7M	Buy	+156,463	New	+$16.8M	7.51%	2

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Strid Group's FBT Position: Q1 2026 in Review

Strid Group held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 1,000 shares worth $201K. The position accounts for 0.02% of the portfolio, ranked #82.

Strid Group first reported a position in FBT in Q4 2015 and has held it in 8 quarters since. The position peaked at $17.7M in Q4 2015. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Strid Group held 1,000 shares of First Trust NYSE Arca Biotechnology Index Fund worth $201K as of Q1 2026.
Strid Group left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Strid Group's portfolio in Q1 2026, its #82 holding.
Strid Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2015 and has held it in 8 quarters since.
Strid Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $17.7M in Q4 2015.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Strid Group's 13F filing for Q1 2026, filed 29 Apr 2026.